NANETS Webinar on COVID-19 for the Neuroendocrine Tumor Community

A panel of 10 neuroendocrine tumor (NET) medical experts will gather for an online conversation about COVID-19 and its impact on NET patients.  Patients, families, and caregivers are invited to submit questions and panelists will answer as many as possible during the online program.  The program, presented by the North American Neuroendocrine Tumor Society (NANETS),  is scheduled for Thursday, April 23 from 8:00 to 9:20 pm, Eastern Time.

Registration is now open.  Register and submit questions here

NANETS COVID-19 Program, April 23, 2020_collage_3


The panelists are:

Medical Oncology

Emily Bergsland, MD, University of California San Francisco, School of Medicine

Daniel Halperin, MD, University of Texas, MD Anderson Cancer Center

Heloisa Soares, MD, PhD, Huntsman Cancer Institute, University of Utah Health



Alexandra Gangi, MD, Cedars Sinai, Samuel Oschin Comprehensive Cancer Center

James Howe, MD, University of Iowa, Carver College of Medicine



David Metz, MD,  University of Pennsylvania, Perelman Center for Advanced Medicine


Nuclear Medicine

Lisa Bodei, MD, PhD, Memorial Sloan Kettering Cancer Center


Interventional Radiology

Michael Soulen, MD, Hospital of the University of Pennsylvania



Arvind Dasari, MD, medical oncologist, University of Texas, MD Anderson Cancer Center

Joseph Dillon, MD, endocrinologist, University of Iowa, Carver College of Medicine


NANETS and its panel participants recognize every patient situation is unique, and all decisions should be made in consultation with a patient’s health care providers.

NANETS collaborated with several NET patient organizations to bring this event to the NET community. The Carcinoid Cancer Foundation is proud to be one of the collaborators for the program.


Print Friendly, PDF & Email